End-of-day quote
Thailand S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
1.91
THB
|
-1.04%
|
|
-4.50%
|
+1.60%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
1,163
|
1,265
|
1,231
|
1,505
|
1,037
|
535.8
|
Enterprise Value (EV)
1 |
1,290
|
1,379
|
1,343
|
1,728
|
1,164
|
579
|
P/E ratio
|
9.03
x
|
11.9
x
|
10.3
x
|
27.5
x
|
-50.3
x
|
-7.26
x
|
Yield
|
3.92%
|
4.5%
|
7.41%
|
3.03%
|
-
|
-
|
Capitalization / Revenue
|
1.25
x
|
1.39
x
|
1.2
x
|
1.3
x
|
0.99
x
|
0.6
x
|
EV / Revenue
|
1.39
x
|
1.51
x
|
1.31
x
|
1.49
x
|
1.12
x
|
0.65
x
|
EV / EBITDA
|
7.73
x
|
9.58
x
|
9.32
x
|
32.6
x
|
86
x
|
-16
x
|
EV / FCF
|
14.8
x
|
42.2
x
|
18.9
x
|
-18.3
x
|
-10.8
x
|
4.58
x
|
FCF Yield
|
6.74%
|
2.37%
|
5.29%
|
-5.47%
|
-9.26%
|
21.8%
|
Price to Book
|
2.97
x
|
2.82
x
|
2.59
x
|
3.01
x
|
1.47
x
|
0.85
x
|
Nbr of stocks (in thousands)
|
228,000
|
228,000
|
228,000
|
228,000
|
285,000
|
285,000
|
Reference price
2 |
5.100
|
5.550
|
5.400
|
6.600
|
3.640
|
1.880
|
Announcement Date
|
2/21/19
|
2/20/20
|
2/18/21
|
2/28/22
|
2/28/23
|
2/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
929.4
|
910.7
|
1,023
|
1,159
|
1,043
|
888.3
|
EBITDA
1 |
166.9
|
143.9
|
144.2
|
53.08
|
13.54
|
-36.29
|
EBIT
1 |
157.7
|
134.8
|
131.7
|
38.46
|
-2.66
|
-54.63
|
Operating Margin
|
16.97%
|
14.8%
|
12.88%
|
3.32%
|
-0.25%
|
-6.15%
|
Earnings before Tax (EBT)
1 |
146.7
|
121.3
|
139.4
|
59.43
|
-14.2
|
-64.7
|
Net income
1 |
128.7
|
106.7
|
120
|
54.7
|
-20.11
|
-73.76
|
Net margin
|
13.85%
|
11.71%
|
11.73%
|
4.72%
|
-1.93%
|
-8.3%
|
EPS
2 |
0.5647
|
0.4679
|
0.5264
|
0.2399
|
-0.0724
|
-0.2588
|
Free Cash Flow
1 |
86.91
|
32.63
|
71.03
|
-94.43
|
-107.8
|
126.4
|
FCF margin
|
9.35%
|
3.58%
|
6.94%
|
-8.15%
|
-10.33%
|
14.23%
|
FCF Conversion (EBITDA)
|
52.09%
|
22.68%
|
49.27%
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
67.51%
|
30.59%
|
59.18%
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2000
|
0.2500
|
0.4000
|
0.2000
|
-
|
-
|
Announcement Date
|
2/21/19
|
2/20/20
|
2/18/21
|
2/28/22
|
2/28/23
|
2/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
127
|
113
|
112
|
223
|
127
|
43.2
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.7604
x
|
0.7866
x
|
0.7789
x
|
4.201
x
|
9.372
x
|
-1.192
x
|
Free Cash Flow
1 |
86.9
|
32.6
|
71
|
-94.4
|
-108
|
126
|
ROE (net income / shareholders' equity)
|
39.4%
|
25.4%
|
26%
|
11.2%
|
-3.34%
|
-11.1%
|
ROA (Net income/ Total Assets)
|
14%
|
11.8%
|
10.5%
|
2.65%
|
-0.15%
|
-3.03%
|
Assets
1 |
918.7
|
907.4
|
1,142
|
2,064
|
13,302
|
2,433
|
Book Value Per Share
2 |
1.720
|
1.970
|
2.080
|
2.190
|
2.480
|
2.200
|
Cash Flow per Share
2 |
0.0300
|
0.0300
|
0.0500
|
0.2100
|
0.8900
|
0.8800
|
Capex
1 |
4.06
|
57.3
|
24.1
|
21.1
|
29.1
|
14.5
|
Capex / Sales
|
0.44%
|
6.29%
|
2.36%
|
1.82%
|
2.79%
|
1.63%
|
Announcement Date
|
2/21/19
|
2/20/20
|
2/18/21
|
2/28/22
|
2/28/23
|
2/27/24
|
|
1st Jan change
|
Capi.
|
---|
| +1.60% | 14.85M | | +4.41% | 103B | | +1.20% | 68.41B | | +44.29% | 39.97B | | +15.99% | 38.97B | | +5.14% | 33.12B | | +5.29% | 19.41B | | +12.32% | 16.73B | | +8.31% | 15.34B | | +17.69% | 15.07B |
Other Commodity Chemicals
|